FDAFDA · Food and drugs·Recall number D-1095-2023
Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale -Bardez, Goa 403513, India, Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-295-01
Published August 30, 2023 · Recall initiated: August 14, 2023
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent: Out of Specification for Assay Test at the 3-month time point.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Distributor
- nationwide in the U.S.
- UPC
- 0368462294017
- Lot
- Batch # 19224744
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.